Key Takeaways Infant formula makers Abbott and Reckitt saw their stocks decline Friday after a judge ruled plaintiffs could ...

A Missouri judge has ordered Abbott Laboratories and Reckitt Benckiser unit Mead Johnson to face a new trial over allegations ...

Abbott Laboratories and Reckitt Benckiser Group Plc shares fell as a judge ordered a new trial after rejecting a verdict that ...

Back in October, a jury found North Chicago-based Abbott and Reckitt’s formula subsidiary Mead Johnson not responsible for a ...

The U.S. Food and Drug Administration will step up its testing for heavy metals in infant formula and review nutrients ...

Shares of Abbott Laboratories and Reckitt Benckiser fell Friday after a judge ruled a new trial could be heard involving a case on their infant formula products that had already seen a ruling in their ...

March 14, 2025 Abbott, Reckitt face new trial over premature infant formula A Missouri judge has ordered Abbott Laboratories and Reckitt Benckiser unit Mead Johnson to face a new trial over ...

Abbott Laboratories' medical device business is executing well, with double-digit growth in structural heart and diabetes.

The U.S. Food and Drug Administration is taking steps to enhance its efforts to ensure the ongoing quality, safety, nutritional adequacy, and ...

Abbott and Reckitt said they would appeal. Abbott spokesperson Scott Stoffel said the jury had reached the correct decision, based on evidence from scientists and governmental regulators who have ...

Infant formula makers Abbott and Reckitt saw their stocks decline Friday after a judge ruled plaintiffs could pursue a new trial against the companies. A jury in October found the companies not ...